News | March 31, 2026
Roche launches groundbreaking multiplex test to boost blood safety
The new assay consolidates screening for four major viral threats into a single workflow
The new assay consolidates screening for four major viral threats into a single workflow
Price of the starting dose of Ozempic and Wegovy reduced by 36% and 48% respectively
Beyond clinical trials, real-world evidence is adding weight to AbbVie’s claims
High-level results from the Phase III OBERON and TITANIA trials revealed that the first-in-class monoclonal antibody reduced the annual rate of moderate-to-severe COPD exacerbations compared with placebo
The programme aims to provide critical healthcare services to approximately 4 lakh people in remote and resource-scarce communities
They stressed that while the drug is clinically proven to support weight and blood sugar control, it must be prescribed only after careful patient evaluation and used under strict medical supervision.
The collaboration highlights the rising importance of intranasal delivery in developing non-vaccine approaches to respiratory disease prevention
The patent protects antiviral compounds developed by the company that inhibit Vacuolar ATPase (V-ATPase) activity in cells, a mechanism involved in viral infection pathways
The company, part of pharma powerhouse AbbVie, will showcase the findings—and the next evolution of its AA Signature framework—at AMWC 2026 in Monaco,
Subscribe To Our Newsletter & Stay Updated
